Clinical trials: CLDN18.2-positive Advanced Solid Tumor
CLDN18.2-positive Advanced Solid Tumor
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
This study consists of two research phases: Phase Ib (includes dose escalation stage and efficacy expansion stage): To explore the safety, tolerability and initial efficacy of SHR-A1904 in the treatment of CLDN18.2-positive…
- Trial name
- NCT06350006
- Testing
- SHR-A1904; Adebrelimab, SHR-A1904; CAPOX; Adebrelimab
- Where
- China
- Volunteers
- 924 people
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.